ES2184431T3 - Derivados de (alfa-aminofosfino) peptidos y composiciones que los contienen. - Google Patents

Derivados de (alfa-aminofosfino) peptidos y composiciones que los contienen.

Info

Publication number
ES2184431T3
ES2184431T3 ES99914616T ES99914616T ES2184431T3 ES 2184431 T3 ES2184431 T3 ES 2184431T3 ES 99914616 T ES99914616 T ES 99914616T ES 99914616 T ES99914616 T ES 99914616T ES 2184431 T3 ES2184431 T3 ES 2184431T3
Authority
ES
Spain
Prior art keywords
group
substituted
hydrogen atom
phenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99914616T
Other languages
English (en)
Inventor
Bernard Roques
Marie-Claude Fournie-Zaluski
Xuixiong Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2184431T3 publication Critical patent/ES2184431T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32Esters thereof
    • C07F9/3258Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3264Esters with hydroxyalkyl compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32Esters thereof
    • C07F9/3205Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211Esters of acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compuesto de **fórmula** en la que R1 y R2 representan cada uno un átomo de hidrógeno o bien R1 y R2, tomados conjuntamente, forman un grupo insaturado de la fórmula R¿ (R-) C=, en la que, R¿ representa un grupo fenilo monosustituído en posición 2 por un grupo hidroxi o un grupo fenilo disubstituído, en posición 2, por un grupo hidroxi y, en posición 4 ó 5, sea por un átomo de halógeno o por un grupo nitro, o bien por un grupo hidroxi, o por un grupo alcoxi -OR9, R- representa un grupo fenilo, un grupo fenilo sustituido por 1 a 5 átomos de halógeno o un grupo heterocíclico aromático, R3 representa un átomo de hidrógeno, un grupo alquilo o un grupo alquenilo de 1 a 6 átomos de carbono; pudiendo estar estos dos últimos grupos sustituidos por: un grupo hidroxi o un grupo alcoxi -OR9, un grupo fenilo o un grupo bencilo, un grupo sulfanilo, un grupo alquilsulfanilo - SR9 o un grupo alquilsulfanilo oxidado sobre el átomo de azufre -S (O) R9, un grupo amino, un grupo -NHR9 ó -NR9R10, eventualmenteoxidado sobre el átomo de nitrógeno o un grupo guanidino H2N-C (=NH) -NH-, un grupo cicloalquilo o cicloaquilmetilo, un grupo fenilo, un grupo bencilo, pudiendo estar sustituidos sobre el grupo fenilo por 1 ó 2 de los sustituyentes siguientes : un átomo de halógeno, un grupo hidroxi, un grupo alcoxi -OR9 un grupo alquilsulfanilo -SR9 o un grupo alquilsulfanilo oxidado sobre el átomo de azufre, un grupo amino o un grupo -NHR9 ó un grupo -NR9R10 eventualmente oxidado sobre el átomo de nitrógeno, un grupo nitro, un grupo fenilo, un grupo alquilo de 1 a 4 átomos de carbono, un grupo metilo sustituido por un grupo heterocíclico aromático o saturado, pudiendo estar los heteroátomos oxidados en forma de N-óxido ó de S-óxido, R4 representa un grupo -CH (X) -O-C (O) -Y.
ES99914616T 1998-04-22 1999-04-20 Derivados de (alfa-aminofosfino) peptidos y composiciones que los contienen. Expired - Lifetime ES2184431T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9805009A FR2777780B1 (fr) 1998-04-22 1998-04-22 Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
ES2184431T3 true ES2184431T3 (es) 2003-04-01

Family

ID=9525515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99914616T Expired - Lifetime ES2184431T3 (es) 1998-04-22 1999-04-20 Derivados de (alfa-aminofosfino) peptidos y composiciones que los contienen.

Country Status (11)

Country Link
US (1) US6391866B1 (es)
EP (1) EP1073664B1 (es)
JP (1) JP2002512250A (es)
AT (1) ATE226589T1 (es)
AU (1) AU3336599A (es)
CA (1) CA2329637A1 (es)
DE (1) DE69903620T2 (es)
DK (1) DK1073664T3 (es)
ES (1) ES2184431T3 (es)
FR (1) FR2777780B1 (es)
WO (1) WO1999054336A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823212B1 (fr) * 2001-04-10 2005-12-02 Inst Nat Sante Rech Med Inhibiteurs de la toxine botulique de type b
FR2931151A1 (fr) 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
FR2934267B1 (fr) 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
FR2997081B1 (fr) 2012-10-23 2015-11-27 Pharmaleads Inhibiteurs mixtes de l'aminopeptidase n et de la neprilysine
FR3044227B1 (fr) * 2015-11-30 2017-11-24 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires
FR3098217B1 (fr) 2019-07-05 2023-04-21 Pharmaleads N-Formylhydroxylamines en tant qu’inhibiteurs mixtes de l’aminopeptidase N (APN) et de la néprilysine (NEP)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
IT1270260B (it) 1994-06-21 1997-04-29 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
WO1996033201A1 (en) * 1995-04-21 1996-10-24 Centre National De La Recherche Scientifique (Cnrs) Acyclovir derivatives as antiviral agents
IT1276710B1 (it) * 1995-06-14 1997-11-03 Zambon Spa Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
FR2755135B1 (fr) * 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
DE69903620T2 (de) 2003-06-12
FR2777780B1 (fr) 2001-05-04
EP1073664B1 (fr) 2002-10-23
CA2329637A1 (fr) 1999-10-28
ATE226589T1 (de) 2002-11-15
US6391866B1 (en) 2002-05-21
AU3336599A (en) 1999-11-08
EP1073664A1 (fr) 2001-02-07
FR2777780A1 (fr) 1999-10-29
WO1999054336A1 (fr) 1999-10-28
DK1073664T3 (da) 2003-02-24
DE69903620D1 (de) 2002-11-28
JP2002512250A (ja) 2002-04-23

Similar Documents

Publication Publication Date Title
DK0457686T3 (da) Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
TR199701427T1 (xx) �nsektisidler olarak kullan�lan bisiklik aminler.
ES2064517T3 (es) Compuestos de piridinosulfonamida sustituida, composicion herbicida que los contiene y metodo para la preparacion de estos compuestos.
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
ES2075350T3 (es) Compuestos heterociclicos antiemeticos y supresores de la migraña, y composiciones farmaceuticas que los contienen.
MX9300988A (es) Agentes antineoplasticos de quinobenzoxazina, quinobenzotiazina y pirido-acridina y composicion farmaceutica que los contiene.
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
DK0666857T3 (da) Fremgangsmåde til fremstilling af taxanderivater
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
HRP20000508B1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
DK0456209T3 (da) Bis(alkylsubstituerede-4-hydroxyphenylthio)alkananaloger som inhibitorer af kataraktdannelse
ES2184431T3 (es) Derivados de (alfa-aminofosfino) peptidos y composiciones que los contienen.
MY113518A (en) Benzothiazolone derivatives
TW360654B (en) Oxazolidinone derivatives, their preparation and therapeutical use
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
DE69416683D1 (de) Benzolactam-derivate
ATE380173T1 (de) Verfahren zur herstellung von (2s,3r,4s)-4- hydroxyisoleucin und analoga
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
DK439384A (da) Derivater af 4-(3-alkynyloxy-2-hydroxypropyl)-piperazin-1-yl-n-phenylacetamid, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
TW346483B (en) Benzene derivatives
HRP980646B1 (en) Novel oleandomycin derivatives
EP0967212A4 (en) PYRAZOLINE COMPOUNDS AND THEIR USE AS PLANT DISEASE CONTROL AGENTS
DK0743306T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 5-chlor-imidazol-4-carbaldehyder